𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis

✍ Scribed by Marc C. Chamberlain; Denice D. Tsao-Wei; Susan Groshen

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
98 KB
Volume
106
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Phase II trial of intra-cerebrospinal
A Phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis
✍ Marc C. Chamberlain πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 64 KB

## Abstract ## BACKGROUND Neoplastic meningitis (NM), a metastatic complication of both primary central nervous system and systemic cancer, occurs in 1‐5% of patients with known cancer. Currently available treatment options are limited and provide only modest benefit. The current study was perform

Phase II trial of carboplatin and etopos
Phase II trial of carboplatin and etoposide in metastatic breast cancer
✍ John Crown; Thomas Hakes; Bonnie Reichman; David Lebwohl; Theresa Gilewski; Anto πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 345 KB πŸ‘ 2 views

## Background: High-dose chemotherapy with hematopoietic support produces high rates of response in metastatic breast cancer. to facilitate new high-dose regimens there is a need to identify active agents with toxicity limited to hematopoietic suppression. cisplatin/etoposide is a highly active reg

Phase II trial of paclitaxel, estramusti
Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma
✍ David C. Smith; Christopher H. Chay; Rodney L. Dunn; Jude Fardig; Peg Esper; Kar πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Preclinical data suggest that the combination of intravenous (i.v.) paclitaxel, carboplatin, oral etoposide, and oral estramustine (TEEC) has significant activity in patients with advanced, hormone‐refractory prostate carcinoma. The authors conducted this clinical trial t

Phase ii trial of etoposide and doxorubi
Phase ii trial of etoposide and doxorubicin in advanced head and neck cancer
✍ Gradishar, William J. ;Vokes, Everett E. ;Kies, Merrill S. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 388 KB

## Abstract In an effort to improve the response rate of patients with advanced head and neck cancer, a clinical trial combining two infrequently studied drugs was conducted. Twelve patients with squamous cell carcinoma of the head and neck were treated with 3‐day continuous infusions of etoposide